Compare Galaxy Digital Inc. Class A Common Stock (GLXY) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Galaxy Digital Inc. Class A Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Galaxy Digital Inc. Class A Common Stock trades at $20.37 (market cap $3.90B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 3.2× Galaxy Digital Inc. Class A Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Galaxy Digital Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Galaxy Digital Inc. Class A Common Stock for 1 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| GLXY | HALO | |
|---|---|---|
Market Cap | $3.90B | $12.58B |
Volume | 7,887,173 | 2,179,278 |
Sector | Financials | Health |
52-Week High | $42.86 | $115.22 |
52-Week Low | $16.84 | $61.63 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $6.36B | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Galaxy Digital Inc. Class A Common Stock
Galaxy provides digital-asset financial services and data center infrastructure. Its digital-assets business includes trading, asset management, investment banking, staking, tokenization, and custody technology.
Read more on GLXY →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
